Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolome Changes With Diet-Induced Remission in Pediatric Crohn’s Disease
Mohammed Ghiboub, Susanne Penny, Charlotte M. Verburgt, et al.
Gastroenterology (2022) Vol. 163, Iss. 4, pp. 922-936.e15
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Inflammation and malnutrition in inflammatory bowel disease
Sara Massironi, Chiara Viganò, Andrea Palermo, et al.
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 6, pp. 579-590
Closed Access | Times Cited: 129
Current Nutritional Therapies in Inflammatory Bowel Disease: Improving Clinical Remission Rates and Sustainability of Long-Term Dietary Therapies
Elizabeth A. Reznikov, David L. Suskind
Nutrients (2023) Vol. 15, Iss. 3, pp. 668-668
Open Access | Times Cited: 30
Review article: Mechanisms underlying the effectiveness of exclusive enteral nutrition in Crohn's disease
Sarah L. Melton, Kirstin M. Taylor, Peter R. Gibson, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 57, Iss. 9, pp. 932-947
Open Access | Times Cited: 18
The Crohn’s Disease Exclusion Diet: A Comprehensive Review of Evidence, Implementation Strategies, Practical Guidance, and Future Directions
Rotem Sigall Boneh, Catherine Westoby, Ilan Oseran, et al.
Inflammatory Bowel Diseases (2023) Vol. 30, Iss. 10, pp. 1888-1902
Open Access | Times Cited: 17
Identifying robust biomarkers for the diagnosis and subtype distinction of inflammatory bowel disease through comprehensive serum metabolomic profiling
Ji Eun Kim, Dong Ho Suh, Yu Jin Park, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Tryptophan metabolites profile predict remission with dietary therapy in pediatric Crohn’s disease
Rotem Sigall Boneh, Nikki van der Kruk, Eytan Wine, et al.
Therapeutic Advances in Gastroenterology (2025) Vol. 18
Open Access
Nutritional modulation of the gut microbiome in allogeneic hematopoietic stem cell transplantation recipients
Edoardo Muratore, Davide Leardini, Francesco Baccelli, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 24
Effect of the Crohn’s Disease Exclusion Diet (CDED) on the Fecal Calprotectin Level in Children with Active Crohn’s Disease
Małgorzata Matuszczyk, Monika Meglicka, Anna Wiernicka, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 14, pp. 4146-4146
Open Access | Times Cited: 18
Emerging roles of host and microbial bioactive lipids in inflammatory bowel diseases
Hisako Kayama, Kiyoshi Takeda
European Journal of Immunology (2023) Vol. 53, Iss. 8
Open Access | Times Cited: 10
Formula modifications to the Crohn's disease exclusion diet do not impact therapy success in paediatric Crohn's disease
Emma Landorf, Paul Hammond, Rammy Abu‐Assi, et al.
Journal of Pediatric Gastroenterology and Nutrition (2024) Vol. 78, Iss. 6, pp. 1279-1286
Closed Access | Times Cited: 3
Sustained Diet-Induced Remission in Pediatric Crohn’s Disease Is Associated With Kynurenine and Serotonin Pathways
Mohammed Ghiboub, Rotem Sigall Boneh, Bruno Sovran, et al.
Inflammatory Bowel Diseases (2023) Vol. 29, Iss. 5, pp. 684-694
Open Access | Times Cited: 9
Multi-omics in Crohn's disease: New insights from inside
Chenlu Mu, Qianjing Zhao, Qing Zhao, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 3054-3072
Open Access | Times Cited: 9
The Underlying Changes in Serum Metabolic Profiles and Efficacy Prediction in Patients with Extensive Ulcerative Colitis Undergoing Fecal Microbiota Transplantation
Xia Wu, Li Pan, Weihong Wang, et al.
Nutrients (2023) Vol. 15, Iss. 15, pp. 3340-3340
Open Access | Times Cited: 8
Crohn’s Disease Exclusion Diet for the Treatment of Crohn’s Disease: Real-World Experience from a Tertiary Center
Naomi Fliss‐Isakov, Nathaniel A. Cohen, Ahuva Bromberg, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 16, pp. 5428-5428
Open Access | Times Cited: 8
An update on dietary therapies in paediatric Crohn's disease
Konstantinos Gkikas, Vaios Svolos, Bernadette White, et al.
Current Opinion in Clinical Nutrition & Metabolic Care (2024) Vol. 27, Iss. 3, pp. 304-312
Closed Access | Times Cited: 2
Faecal Bacteriome and Metabolome Profiles Associated with Decreased Mucosal Inflammatory Activity Upon Anti-TNF Therapy in Paediatric Crohn’s Disease
Jakub Hurych, Anna Mascellani, Tereza Lerchová, et al.
Journal of Crohn s and Colitis (2023) Vol. 18, Iss. 1, pp. 106-120
Open Access | Times Cited: 6
The Role of Diet in Pediatric Inflammatory Bowel Disease
Lindsey Albenberg
Gastroenterology Clinics of North America (2023) Vol. 52, Iss. 3, pp. 565-577
Closed Access | Times Cited: 6
The Role of Partial Enteral Nutrition for Induction of Remission in Crohn’s Disease: A Systematic Review of Controlled Trials
Lucía González-Torres, Ana Moreno‐Álvarez, Ana Estefanía Fernández-Lorenzo, et al.
Nutrients (2022) Vol. 14, Iss. 24, pp. 5263-5263
Open Access | Times Cited: 9
Transient Suppression of Bacterial Populations Associated with Gut Health is Critical in Success of Exclusive Enteral Nutrition for Children with Crohn’s Disease
Joseph Runde, Iva Veseli, Emily C. Fogarty, et al.
Journal of Crohn s and Colitis (2023) Vol. 17, Iss. 7, pp. 1103-1113
Open Access | Times Cited: 3
Is Autologous Fecal Microbiota Transfer after Exclusive Enteral Nutrition in Pediatric Crohn’s Disease Patients Rational and Feasible? Data from a Feasibility Test
Hannes Hoelz, Jeannine Heetmeyer, Anastasia Tsakmaklis, et al.
Nutrients (2023) Vol. 15, Iss. 7, pp. 1742-1742
Open Access | Times Cited: 2
Dietary regulation of intestinal stem cells in health and disease
Hancheng Fan, Jiaqiang Wu, Kangping Yang, et al.
International Journal of Food Sciences and Nutrition (2023) Vol. 74, Iss. 7, pp. 730-745
Closed Access | Times Cited: 2
Identifying Robust Biomarkers for the Diagnosis and Subtype Distinction of Inflammatory Bowel Disease through Comprehensive Serum Metabolomic Profiling
Ji Eun Kim, Dong Ho Suh, Yu Jin Park, et al.
Research Square (Research Square) (2024)
Open Access
The Application of Crohn’s Disease Exclusion Diet in Children with Crohn’s Disease
欢 秦
Advances in Clinical Medicine (2024) Vol. 14, Iss. 04, pp. 1660-1665
Closed Access
Ustekinumab affects myofibroblast metabolism to alleviate intestinal fibrosis by targeting KDELC1 in Crohn’s disease through multi-machine learning combined with single-cell sequencing analysis
Su Ma, Yongming Kang, Zhonglin Yang, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
The Association between Nutrient Intake and Inflammatory Bowel Disease Risk: Insights from NHANES Data and Dose-Response Analysis
Ningyang Xiong, Wei Zhang, Yajie Zhang, et al.
Nutrition (2024) Vol. 131, pp. 112632-112632
Closed Access
Page 1 - Next Page

Scroll to top